UTHR Competitors
United Therapeutics Corporation
$595.66
+$7.05(+1.20%)
71
Overall
80
Value
66
Tech
68
Quality
Market Cap
$25.37B
Volume
353.50K
52W Range
$445.81 - $614.23
Target Price
$678.06
UTHR competitors: LLY, GILD, TEVA, PFE, BAX. United Therapeutics Corporation is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
UTHR Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| LLY Eli Lilly and Company | $1437.29 | $1.35T | $35.35 | 0.47% | 63 |
| GILD Gilead Sciences, Inc. | $169.73 | $211.94B | $-0.98 | 1.91% | 68 |
| TEVA Teva Pharmaceutical Industries Limited | $43.24 | $49.47B | $1.94 | - | 65 |
| PFE Pfizer Inc. | $29.45 | $167.35B | $3.04 | 4.38% | 65 |
| BAX Baxter International Inc. | $26.34 | $13.67B | $2.10 | 0.15% | 62 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | UTHR | $595.66 | +1.2% | 353.50K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get United Therapeutics Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW